Researchers at the University of Michigan Health Rogel Cancer Center are testing potato starch supplements as a potential remedy for Graft versus Host Disease (GVHD), a harmful complication in blood or bone marrow stem cell transplant patients. Early findings suggest that potato starch can alter intestinal bacteria byproducts to potentially prevent GVHD, necessitating further investigation through additional clinical trials. Currently, GVHD treatment involves strong medication that risks life-threatening infections.



